RESMED INC — Director's Dealing 2019

May 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-05-24

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-24	ResMed Common Stock	M	11085	$51.25	Acquired	24085	Direct
2019-05-24	ResMed Common Stock	S	11085	$113.435	Disposed	13000	Direct
2019-05-24	ResMed Common Stock	M	9628	$51.25	Acquired	22628	Direct
2019-05-24	ResMed Common Stock	S	9628	$114.00	Disposed	13000	Direct
2019-05-24	ResMed Common Stock	M	23629	$52.02	Acquired	36629	Direct
2019-05-24	ResMed Common Stock	S	23629	$114.00	Disposed	13000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-24	ResMed Common Stock Options	$51.25	M	11085	Disposed	2020-11-13	ResMed Common Stock (11085)	Direct
2019-05-24	ResMed Common Stock Options	$51.25	M	9628	Disposed	2020-11-13	ResMed Common Stock (9628)	Direct
2019-05-24	ResMed Common Stock Options	$52.02	M	23629	Disposed	2021-11-19	ResMed Commmon Stock (23629)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $113.44 to $113.45. The price reported above reflects the weighted average sale price.

F2: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.